<DOC>
	<DOCNO>NCT00637130</DOCNO>
	<brief_summary>The purpose study compare safety IOP-lowering efficacy various low dose travoprost formulation patient open-angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>Safety Intraocular Pressure ( IOP ) Lowering Efficacy Low Dose Travoprost</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Patients 18 year age old , either sex race openangle glaucoma confirm ocular hypertension Other protocoldefined inclusion criterion may apply Age related Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>